CD47 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma (NPC), the coinhibition of miR-200a and CD47 exerts a more potent inhibition of tumor proliferation than the single-block group, but the specific mechanism has not been elucidated clearly [57].